144 related articles for article (PubMed ID: 18849640)
1. Long-term survival and prognostic indicators in small (Pongprasobchai S; Pannala R; Smyrk TC; Bamlet W; Pitchumoni S; Ougolkov A; de Andrade M; Petersen GM; Chari ST
Pancreatology; 2008; 8(6):587-92. PubMed ID: 18849640
[TBL] [Abstract][Full Text] [Related]
2. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.
Wasif N; Bentrem DJ; Farrell JJ; Ko CY; Hines OJ; Reber HA; Tomlinson JS
Cancer; 2010 Jul; 116(14):3369-77. PubMed ID: 20564064
[TBL] [Abstract][Full Text] [Related]
3. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
You DD; Lee HG; Heo JS; Choi SH; Choi DW
J Gastrointest Surg; 2009 Sep; 13(9):1699-706. PubMed ID: 19582512
[TBL] [Abstract][Full Text] [Related]
5. A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.
Kim R; Tsao R; Tan A; Byrne M; Almhanna K; Lazaryan A; Elson P; Pelley RJ
J Gastrointest Surg; 2010 Jul; 14(7):1159-69. PubMed ID: 20446118
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center.
Duffy A; Capanu M; Allen P; Kurtz R; Olson SH; Ludwig E; Klimstra DS; O'Reilly EM
J Surg Oncol; 2009 Jul; 100(1):8-12. PubMed ID: 19384918
[TBL] [Abstract][Full Text] [Related]
7. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study.
Huang L; Jansen L; Balavarca Y; Babaei M; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Primic-Žakelj M; Zadnik V; Besselink MG; Schrotz-King P; Brenner H
BMC Med; 2018 Aug; 16(1):125. PubMed ID: 30126408
[TBL] [Abstract][Full Text] [Related]
8. Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base.
Kooby DA; Gillespie TW; Liu Y; Byrd-Sellers J; Landry J; Bian J; Lipscomb J
Ann Surg Oncol; 2013 Oct; 20(11):3634-42. PubMed ID: 23771249
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.
Mayo SC; Austin DF; Sheppard BC; Mori M; Shipley DK; Billingsley KG
Cancer; 2010 Jun; 116(12):2932-40. PubMed ID: 20336787
[TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection.
Chiang KC; Yeh CN; Lee WC; Jan YY; Hwang TL
World J Gastroenterol; 2009 Sep; 15(34):4305-10. PubMed ID: 19750574
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study.
Huang L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Zadnik V; Primic-Žakelj M; Mägi M; Grützmann R; Besselink MG; Schrotz-King P; Brenner H; Jansen L
BMC Med; 2019 Mar; 17(1):66. PubMed ID: 30905320
[TBL] [Abstract][Full Text] [Related]
12. Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study.
Hart PA; Law RJ; Frank RD; Bamlet WR; Burch PA; Petersen GM; Rabe KG; Chari ST
Am J Gastroenterol; 2014 Sep; 109(9):1484-92. PubMed ID: 25070053
[TBL] [Abstract][Full Text] [Related]
13. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
Colbert LE; Fisher SB; Hardy CW; Hall WA; Saka B; Shelton JW; Petrova AV; Warren MD; Pantazides BG; Gandhi K; Kowalski J; Kooby DA; El-Rayes BF; Staley CA; Adsay NV; Curran WJ; Landry JC; Maithel SK; Yu DS
Cancer; 2013 Sep; 119(17):3148-55. PubMed ID: 23720157
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study.
Bergquist JR; Puig CA; Shubert CR; Groeschl RT; Habermann EB; Kendrick ML; Nagorney DM; Smoot RL; Farnell MB; Truty MJ
J Am Coll Surg; 2016 Jul; 223(1):52-65. PubMed ID: 27049786
[TBL] [Abstract][Full Text] [Related]
15. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
Huang L; Jansen L; Balavarca Y; van der Geest L; Lemmens V; Koerkamp BG; van Santvoort HC; Grützmann R; Besselink MG; Schrotz-King P; Brenner H
Ann Surg; 2021 Dec; 274(6):e554-e563. PubMed ID: 31425290
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic adenocarcinoma in young adults in a moroccan population.
Raissouni S; Rais G; Mrabti H; Raissouni F; Mouzount H; Aitelhaj M; El Khoyaali S; Mohtaram A; Errihani H
J Gastrointest Cancer; 2012 Dec; 43(4):607-11. PubMed ID: 22760710
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.
Scarpa A; Mantovani W; Capelli P; Beghelli S; Boninsegna L; Bettini R; Panzuto F; Pederzoli P; delle Fave G; Falconi M
Mod Pathol; 2010 Jun; 23(6):824-33. PubMed ID: 20305616
[TBL] [Abstract][Full Text] [Related]
18. Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer.
Ma SJ; Oladeru OT; Miccio JA; Iovoli AJ; Hermann GM; Singh AK
JAMA Netw Open; 2019 Aug; 2(8):e199126. PubMed ID: 31411712
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of veteran patients with pancreatic cancer.
Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
[TBL] [Abstract][Full Text] [Related]
20. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]